Pilonidal disease symptoms temporally associated with glucagon-like peptide-1 receptor agonist therapy – a case report

Introduction and importance: Pilonidal disease (PD) is a chronic inflammatory condition associated with secondary infection, most commonly with anaerobic, gut-derived bacteria belonging to the Bacteroidota phylum. Glucagon-like peptide-1 (GLP-1) receptor agonists have been found to alter the gut microbiome and increase the abundance of Bacteroidota . Patients with PD often have other comorbidities, such as obesity, which is now commonly treated with GLP-1 receptor agonists. In this report, we describe three patients with new-onset or recurrent PD symptoms after taking GLP-1 receptor agonists. Case presentation: Three patients with PD presented to our Pilonidal Care Clinic with either new-onset gluteal cleft symptoms or recurrent PD. All three had recently started treatment with GLP-1 receptor agonists. Two patients underwent a Gips procedure, and one required incision and drainage. Wound cultures from two patients grew Prevotella , belonging to the phylum Bacteroidota . All wounds healed successfully after intervention, and all patients resumed taking GLP-1 receptor agonists. Clinical discussion: Pilonidal sinuses are commonly infected with Bacteroidota , and initiating GLP-1 receptor agonists can increase the intestinal population of Bacteroidota. A potential temporal relationship between the initiation of GLP-1 receptor agonists and the development of PD symptoms may exist. Patients with PD who are on GLP-1 receptor agonists should be carefully observed. Conclusion: There may be a temporal association between taking GLP-1 receptor agonists and the development of PD symptoms. Recognition of this possibility may lead to early recognition of pilonidal symptoms in patients and to hypothesis generation for future investigation.

Authors

Publication Details

Journal
International Journal of Surgery Case Reports
Published
2026-11-19
DOI
https://doi.org/10.1097/rc9.0000000000001318
Primary Topic
Anorectal Disease Treatments and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Pilonidal disease symptoms temporally associated with glucagon-like peptide-1 receptor agonist therapy – a case report

Claire T. Abrajano, Bill Chiu, Somin Jo
International Journal of Surgery Case Reports
Anorectal Disease Treatments and Outcomes
article

Pilonidal disease symptoms temporally associated with glucagon-like peptide-1 receptor agonist therapy – a case report

Claire T. Abrajano, Bill Chiu, Somin Jo
article en

Abstract

Introduction and importance: Pilonidal disease (PD) is a chronic inflammatory condition associated with secondary infection, most commonly with anaerobic, gut-derived bacteria belonging to the Bacteroidota phylum. Glucagon-like peptide-1 (GLP-1) receptor agonists have been found to alter the gut microbiome and increase the abundance of Bacteroidota . Patients with PD often have other comorbidities, such as obesity, which is now commonly treated with GLP-1 receptor agonists. In this report, we describe three patients with new-onset or recurrent PD symptoms after taking GLP-1 receptor agonists. Case presentation: Three patients with PD presented to our Pilonidal Care Clinic with either new-onset gluteal cleft symptoms or recurrent PD. All three had recently started treatment with GLP-1 receptor agonists. Two patients underwent a Gips procedure, and one required incision and drainage. Wound cultures from two patients grew Prevotella , belonging to the phylum Bacteroidota . All wounds healed successfully after intervention, and all patients resumed taking GLP-1 receptor agonists. Clinical discussion: Pilonidal sinuses are commonly infected with Bacteroidota , and initiating GLP-1 receptor agonists can increase the intestinal population of Bacteroidota. A potential temporal relationship between the initiation of GLP-1 receptor agonists and the development of PD symptoms may exist. Patients with PD who are on GLP-1 receptor agonists should be carefully observed. Conclusion: There may be a temporal association between taking GLP-1 receptor agonists and the development of PD symptoms. Recognition of this possibility may lead to early recognition of pilonidal symptoms in patients and to hypothesis generation for future investigation.

International Journal of Surgery Case Reports
Anorectal Disease Treatments and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon